NDC 65162-038 – Guaifenesin and Dextromethorphan HBr

Guaifenesin 600 mg/1; Dextromethorphan Hydrobromide 30 mg/1 · Tablet, Extended Release · Oral

Human Otc Drug

Product NDC65162-038

Product details

Brand name
Guaifenesin and Dextromethorphan HBr
Generic name
Guaifenesin and Dextromethorphan HBr
Labeler
Amneal Pharmaceuticals LLC
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA209692
Marketed since
November 1, 2018
Listing expires
December 31, 2026
Pharmacologic class
Expectorant; Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Guaifenesin and Dextromethorphan HBr →

Package NDC codes (3)

Package NDCDescriptionSince
65162-038-031 BOTTLE in 1 CARTON (65162-038-03) / 30 TABLET, EXTENDED RELEASE in 1 BOTTLENov 1, 2018
65162-038-061 BOTTLE in 1 CARTON (65162-038-06) / 60 TABLET, EXTENDED RELEASE in 1 BOTTLENov 1, 2018
65162-038-172 BLISTER PACK in 1 CARTON (65162-038-17) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACKNov 1, 2018

Other Guaifenesin and Dextromethorphan HBr products